ES2736148T3 - Preparación mejorada de polímeros con impresión molecular - Google Patents

Preparación mejorada de polímeros con impresión molecular Download PDF

Info

Publication number
ES2736148T3
ES2736148T3 ES07702501T ES07702501T ES2736148T3 ES 2736148 T3 ES2736148 T3 ES 2736148T3 ES 07702501 T ES07702501 T ES 07702501T ES 07702501 T ES07702501 T ES 07702501T ES 2736148 T3 ES2736148 T3 ES 2736148T3
Authority
ES
Spain
Prior art keywords
mips
mip
template
composition
capture agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07702501T
Other languages
English (en)
Spanish (es)
Inventor
Jesper Svenning Kristensen
Klaus Gregorius Nielsen
Nicolas Otto Krogh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mipsalus ApS
Original Assignee
Mipsalus ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mipsalus ApS filed Critical Mipsalus ApS
Application granted granted Critical
Publication of ES2736148T3 publication Critical patent/ES2736148T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26—Synthetic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26—Synthetic macromolecular compounds
    • B01J20/268—Polymers created by use of a template, e.g. molecularly imprinted polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/305—Addition of material, later completely removed, e.g. as result of heat treatment, leaching or washing, e.g. for forming pores
    • B01J20/3057—Use of a templating or imprinting material ; filling pores of a substrate or matrix followed by the removal of the substrate or matrix
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Thermal Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES07702501T 2006-02-21 2007-02-21 Preparación mejorada de polímeros con impresión molecular Active ES2736148T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74333006P 2006-02-21 2006-02-21
DKPA200600248 2006-02-21
PCT/DK2007/000083 WO2007095949A2 (en) 2006-02-21 2007-02-21 Improved preparation of molecular imprinted polymers

Publications (1)

Publication Number Publication Date
ES2736148T3 true ES2736148T3 (es) 2019-12-26

Family

ID=38038548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07702501T Active ES2736148T3 (es) 2006-02-21 2007-02-21 Preparación mejorada de polímeros con impresión molecular

Country Status (11)

Country Link
US (1) US8287908B2 (https=)
EP (1) EP1988993B1 (https=)
JP (1) JP2009527471A (https=)
KR (1) KR101475528B1 (https=)
AU (1) AU2007218396C1 (https=)
CA (1) CA2642097C (https=)
DK (1) DK1988993T3 (https=)
ES (1) ES2736148T3 (https=)
IL (1) IL193416A (https=)
RU (1) RU2437665C2 (https=)
WO (1) WO2007095949A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201200878D0 (en) * 2012-01-19 2012-02-29 British American Tobacco Co Polymer compositions
EP2477706B1 (en) * 2009-09-16 2020-12-23 Mipsalus Aps Molecular imprinted polymers for use in a treatment of a disease
CN101942062B (zh) * 2010-08-09 2013-07-17 南开大学 一种用于催化有机磷农药降解的表面印迹聚合物及制备方法
WO2012031128A2 (en) * 2010-09-01 2012-03-08 The Research Foundation Of State University Of New York Microorganism imprinted polymers with integrated emission sites, and methods of making and using same
US9084727B2 (en) * 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
CA2864908C (en) 2012-02-28 2021-01-12 Mipsalus Aps Preparation of molecular imprinted polymers by cross-linking
US9557250B2 (en) 2012-05-17 2017-01-31 The Board Of Trustees Of The Leland Stanford Junior University Devices and methods for separating particles
RU2515455C2 (ru) * 2012-07-29 2014-05-10 Закрытое Акционерное Общество "Аксион-Редкие И Драгоценные Металлы" Способ получения адаптивно-селективного к редкоземельным металлам ионообменного материала
US11051529B2 (en) 2015-01-13 2021-07-06 The Decaf Company, Llc Programmable polymer caffeine extraction
US20170172946A1 (en) * 2015-12-21 2017-06-22 Stephan Hau Micro-solid phase extraction
WO2017157980A1 (en) 2016-03-15 2017-09-21 Mipsalus Aps Detection method and means therefor
AT518590A3 (de) * 2016-04-29 2022-09-15 Mosbach Klaus Speicherung von binärkodes in molekular geprägten polymeren
CA3067123A1 (en) 2017-06-29 2019-01-03 Mipsalus Aps Molecular imprinted polymers targeting phenylalanine
CN111151227A (zh) * 2019-10-21 2020-05-15 深圳市易瑞生物技术股份有限公司 半分子印迹材料及其制备方法和应用
US10828322B1 (en) 2019-11-29 2020-11-10 Claves Life Sciences Limited Molecularly imprinted polymers for sequestering acetate and other molecules
RU2765188C1 (ru) * 2020-11-03 2022-01-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ получения селективного сорбента для твердофазной экстракции
CN113231034A (zh) * 2021-04-21 2021-08-10 华南师范大学 一种dgt结合相及其制备方法和应用
WO2025153614A1 (en) 2024-01-16 2025-07-24 Mipsalus Aps Cross-linked polymers and their use in methods of binding cations

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03147025A (ja) 1989-11-01 1991-06-24 Mitsubishi Electric Corp ベーシックインタプリタ
SE9203435D0 (sv) * 1992-11-11 1992-11-11 Georg Vlatakis Fondation For R Framstaellande av artificiella antikroppar med molekylavtrycksmetoden samt deras anvaendning vid analys
WO1994019693A1 (en) * 1993-02-24 1994-09-01 Baxter Diagnostics Inc. Immobilization of specific binding assay reagents
US5994110A (en) * 1995-02-10 1999-11-30 Mosbach; Klaus Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof
JPH11507402A (ja) * 1995-05-26 1999-06-29 アイジェン・インコーポレーテッド 分子的にインプリントされた粒状ポリマー及び同ポリマーのペルフロオロカーボン液中における安定化懸濁重合
US5786428A (en) * 1996-03-27 1998-07-28 California Institute Of Technology Adsorbents for amino acid and peptide separation
SE9802092D0 (sv) * 1998-06-12 1998-06-12 Boerje Sellergren Selective adsorbent
SE9900121D0 (sv) * 1999-01-14 1999-01-14 Klaus Mosbach Molecularly imprinted microspheres prepared using precipitation polymerization
US6217901B1 (en) 1999-05-25 2001-04-17 Alnis, Llc Liposome-assisted synthesis of polymeric nanoparticles
GB9925056D0 (en) * 1999-10-23 1999-12-22 Univ Cranfield Preparation of biologically-active molecules by template polymerization
SE9903958D0 (sv) * 1999-11-02 1999-11-02 Boerje Sellergren Porous materials for selective binding or transport of molecular guests
US6379599B1 (en) * 2000-01-10 2002-04-30 Council Of Scientific And Industrial Research Process for the preparation of molecularly imprinted polymers useful for separation of enzymes
US6458599B1 (en) * 2000-02-18 2002-10-01 Aspira Biosystems, Inc. Compositions and methods for capturing, isolating, detecting, analyzing and quantifying macromolecules
US6638498B2 (en) 2000-06-30 2003-10-28 Semorex Inc. Molecularly imprinted polymers for the treatment and diagnosis of medical conditions
US6660176B2 (en) * 2001-01-24 2003-12-09 Virginia Commonwealth University Molecular imprinting of small particles, and production of small particles from solid state reactants
SE0100631D0 (sv) * 2001-02-26 2001-02-26 Klaus Mosbach Molecularly imprinted scintillation polymers
JP2003147025A (ja) * 2001-04-05 2003-05-21 Sekisui Chem Co Ltd 胆汁酸特異的認識ポリマー及びコレステロール低下剤
WO2002084292A1 (en) * 2001-04-11 2002-10-24 Aspira Biosystems, Inc. Inverse emulsion methods of making polymeric imprint beads
JP2003147205A (ja) * 2001-11-15 2003-05-21 Kanegafuchi Chem Ind Co Ltd 光学材料用硬化性組成物、光学用材料、光学用材料の製造方法および光学材料を用いた発光ダイオード
WO2003101580A1 (en) * 2002-05-31 2003-12-11 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Solid mycoctoxin carriers
GB0511116D0 (en) * 2005-06-01 2005-07-06 Univ Cranfield Preparation of soluble and collodial imprinted polymers by living polymerization

Also Published As

Publication number Publication date
DK1988993T3 (da) 2019-07-01
CA2642097C (en) 2016-08-02
US20090104277A1 (en) 2009-04-23
AU2007218396C1 (en) 2013-01-17
IL193416A0 (en) 2009-05-04
RU2437665C2 (ru) 2011-12-27
AU2007218396A1 (en) 2007-08-30
RU2008134011A (ru) 2010-03-27
WO2007095949A2 (en) 2007-08-30
KR101475528B1 (ko) 2014-12-22
US8287908B2 (en) 2012-10-16
IL193416A (en) 2013-02-28
EP1988993B1 (en) 2019-04-17
JP2009527471A (ja) 2009-07-30
KR20080096834A (ko) 2008-11-03
AU2007218396B2 (en) 2011-07-28
WO2007095949A3 (en) 2008-01-10
EP1988993A2 (en) 2008-11-12
CA2642097A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
ES2736148T3 (es) Preparación mejorada de polímeros con impresión molecular
Alvarez-Lorenzo et al. Molecularly imprinted polymers for drug delivery
ES2557577T3 (es) Preparación de polímeros con impronta molecular
JP6063962B2 (ja) 架橋による分子インプリントポリマーの製造
EP1292637A1 (en) Molecular imprinting
NZ570505A (en) Improved preparation of molecular imprinted polymers
AU5439794A (en) Artificial antibodies, method of producing the same and use thereof
Sullivan et al. Stimuli‐responsive molecularly imprinted materials: fundamentals and applications
Ciardelli et al. The relevance of the transfer of molecular information between natural and synthetic materials in the realisation of biomedical devices with enhanced properties
Lee et al. Design of size-tunable molecularly imprinted polymer for selective adsorption of pharmaceuticals and biomolecules
HK1125065B (en) Improved preparation of molecular imprinted polymers
HK1125065A (en) Improved preparation of molecular imprinted polymers
Yiu et al. Molecular Imprinting: The Key and Lock Match
Shea et al. Molecularly Imprinted Polymers. Synthetic Receptors for Small Molecules, Peptides and Proteins. The Evolution of a “Plastic Antibody”.
Mier Salazar Synthesis of Multifunctional Nano and Micro-Structures for the Specific Isolation and Recovery of Biomarkers From Biological Fluids and Multifunctional Materials for Light/Energy Conversion
CN112473633A (zh) 一种恩诺沙星限进表面分子印迹材料及其制备方法和应用